Digital Inhaler Use in Obstructive Lung Disease Care
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCedars-Sinai Medical Center
About this trial
This is a pilot study to evaluate the role digital inhaler technology on patients with obstructive lung disease in preventing admissions and exacerbation, as well as improving symptom control. The primary objective is to evaluate feasibility of study protocol, patient recruitment, and patient retention with goal recruitment of 20 participants, 60% recruitment success, and 60% retention rate for 6 months duration. The secondary objectives are the evaluation of patient admission rate, exacerbation rates, and symptoms control with use of digital inhaler technology The subject population will be patients with physician diagnosed obstructive lung disease.
Eligibility criteria
Qualifiers
Any sex
Over the age of 18 years.
Physician-diagnosed obstructive lung disease
Speak, read, and understand English.
Disqualifiers
Physically disabled such that they are incapable of using digital devices or metered dose inhalers.
Suffer from any visual, hearing or cognitive impairment that cannot be corrected enough to operate the devices properly. Mild/moderate vision loss and mild hearing loss may be included with appropriate corrective measures that do not affect the device usage.
Suffering from serious uncontrolled medical conditions that may interfere with study conduct.
Inability or unwillingness of the participant to give written informed consent.
Trial design
Treatments tested in this trial
- Digital Inhaler Attachment
Treatment groups
20 Participants
are divided into 1 treatment groupSponsors and collaborators
Cedars-Sinai Medical Center
Lead sponsor
Breathe California, Los Angeles County
Collaborator
Source ClinicalTrials.gov